Piper Jaffray Upgrades Arena Pharma (ARNA) to Overweight
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Rating Summary:
10 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 13
Rating Summary:
10 Buy, 13 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 8 | New: 13
Join SI Premium – FREE
Piper Jaffray upgraded Arena Pharma (NASDAQ: ARNA) from Neutral to Overweight, price target raised from $1.50 to $3.00.
For an analyst ratings summary and ratings history on Arena Pharma click here. For more ratings news on Arena Pharma click here.
Shares of Arena Pharma closed at $1.27 yesterday.
For an analyst ratings summary and ratings history on Arena Pharma click here. For more ratings news on Arena Pharma click here.
Shares of Arena Pharma closed at $1.27 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Outperform
- Pivotal Research Upgrades Sirius XM Radio (SIRI) to Buy, 'Free Cash Flow Acceleration Story'
- Munich Re (MUV2:GR) (MURGY) PT Raised to EUR464 at RBC Capital
Create E-mail Alert Related Categories
UpgradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
